Sorry, you need to enable JavaScript to visit this website.

Branded vs. Generic

  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Related Articles

Science & Innovation

Developing a Path Forward in Cancer Cachexia

Across disciplines, therapeutic areas, and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition associated with certain chronic conditions.

Real People

How One Woman with Multiple Myeloma Found Strength—and Gratitude—in Adversity

September’s Blood Cancer Awareness Month is a time to raise awareness of hematologic cancers and share the stories of those living with the disease.

Programs & Initiatives

Pfizer's Global Health Fellows Program: Leveraging Colleagues’ Expertise to Help Improve Healthcare Access Around the World

Global Health Fellows (GHF) is Pfizer’s signature skills-based volunteering program, empowering colleagues to lend their skills and expertise.

How Drugs Are Made

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Clinical Trials

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details